<?xml version="1.0" encoding="UTF-8"?>
<p>The use of cannabinoids in the treatment of epilepsy in dogs was discussed in another clinical study. In this study, cannabinoids were given as an adjunct therapy to antiepileptic therapy for 12 dogs. Two dogs in the CBD group developed ataxia and had to be withdrawn. In the end, nine dogs in the CBD group were compared with seven in the placebo group. Reduced seizure frequencies were observed in the CBD group, however, the proportion of dogs considered responders to treatment (â‰¥50% decrease in seizure activity) was similar between groups. The dogs showed no detectable analytical plasma CBD concentrations at any assessment point [
 <xref rid="B103-animals-11-00892" ref-type="bibr">103</xref>].
</p>
